Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Офтальмология / Английские материалы / Oxford American Handbook of Ophthalmology_Tsai, Denniston, Murray_2011

.pdf
Скачиваний:
0
Добавлен:
28.03.2026
Размер:
11 Mб
Скачать

726

INDEX

 

 

 

 

optic nerve hypoplasia, 535

retention cyst, 153

herpes simplex keratitis,

 

 

tilted disc, 535

toxic conjunctivitis, 152

174–6

 

 

Congenital rubella, 619

viral conjunctivitis, 142–3

herpes zoster

 

 

clinical features of, 620

adenovirus, 142

ophthalmicus, 177–8

 

 

Congenital stationary night

molluscum contagiosum,

keratoplasty

 

 

blindness (CSNB), 458

142–3

complications, 207–8

 

 

Congenital syphilis, 619

herpes simplex, 143

principles, 205–6

 

 

clinical features of, 620

Conjunctival intraepithelial

microbial keratitis

 

 

Congenital toxoplasmosis,

neoplasia, 156

acanthamoeba, 170–2

 

 

619

Conjunctival Kaposi

assessment, 166

 

 

clinical features of, 620

sarcoma, 157

treatment, 168–9

 

 

Congruousness, 48

Conjunctival lymphoma, 157

neurotrophic keratopathy,

 

 

Conjunctiva, 106

Conjunctival

200

 

 

allergic conjunctivitis, 146–7

microvasculopathy, 349

ophthalmic signs, 666–7

 

 

atopic

Conjunctival nevus, 154

peripheral corneal

 

 

keratoconjunctivitis,

Conjunctival squamous cell

diseases

 

 

147

carcinoma, 156–7

dellen, 199

 

 

seasonal and

Connective tissue disease,

marginal keratitis, 198

 

 

perennial allergic

631

phlyctenulosis, 198–9

 

 

rhinoconjunctivitis,

Connective tissues

rosacea associated

 

 

146

disorders, 643

keratitis, 198

 

 

vernal

Consecutive exotropia, 587

Terrien’s marginal

 

 

keratoconjunctivitis,

Contact lenses

degeneration, 199

 

 

146–7

complications, 215–16

peripheral ulcerative

 

 

anatomy and physiology,

fitting, 213–14

keratitis, 195–7

 

 

136

nonrefractive contact

physiology, 160–1

 

 

macroscopic, 136

lenses, 214

recurrent erosion

 

 

microscopic, 136

refractive contact lenses,

syndrome, 180

 

 

tear film, 136

213–14

refractive surgery, 209–10

 

 

bacterial conjunctivitis, 140

lens notation, 212

Thygeson’s superficial

 

 

acute, 140

material, 211–12

punctate keratopathy,

 

 

gonococcus, 140–1

hard lenses, 211

179

 

 

chlamydial conjunctivitis,

hydrogel (soft), 211

Corneal degenerative

 

 

144–5

rigid gas permeable, 211

disease, 181–2, 183–4

 

 

adult inclusion

silicone hydrogel, 212

arcus, 181

 

 

conjunctivitis, 144

wearing schedule, 212

band keratopathy, 183

 

 

trachoma, 144–5

Continuous curvilinear

cornea farinata, 181

 

 

cicatricial conjunctivitis,

capsulorhexis, 242–3

crocodile shagreen, 181

 

 

148–9

Contrast sensitivity, 11

primary lipid keratopathy,

 

 

primary, 148–9

Conventional vs. disposable

181

 

 

secondary, 149

lenses, 212

Salzmann nodular

 

 

clinical features, 139

Copper foreign body, 96

degeneration, 183–4

 

 

concretions, 153

Cornea, 600

secondary lipid

 

 

conjunctival signs, 137

anatomy, 160–1

keratopathy, 181–2

 

 

keratoconjunctivitis sicca,

contact lenses

Vogt’s limbal girdle, 181

 

 

150–1

complications, 215–16

Corneal diagrams, 164

 

 

ligneous conjunctivitis, 152

fitting, 213–14

Corneal dystrophies

 

 

nonpigmented conjunctival

outline, 211–12

anterior, 185–6

 

 

lesions, 156–7

corneal degenerative

epithelial basement

 

 

benign, 156

disease, 181–2, 183–4

membrane

 

 

malignant, 156–7

corneal diagrams, 164

dystrophy, 185

 

 

premalignant, 156

corneal dystrophies

Meesman’s dystrophy,

 

 

ophthalmic signs, 665

anterior, 185–6

185–6

 

 

Parinaud’s oculoglandular

posterior, 191–2

Reis–Buckler dystrophy,

 

 

syndrome, 152

stromal, 187–8, 189–90

185

 

 

pigmented conjunctival

corneal ectasias, 193–4

central cloudy dystrophy,

 

 

lesions, 154–5

corneal signs, 162–3

190

 

 

benign, 154

deposition keratopathies,

fleck dystrophy, 190

 

 

malignant, 155

203

posterior, 191–2

 

 

premalignant, 154

exposure keratopathy,

congenital hereditary

 

 

pinguecula, 152

201–2

endothelial

 

 

pterygium, 152–3

fungal keratitis, 172–3

dystrophy, 192

 

 

INDEX

727

Fuchs’ endothelial

Crowding, 7

mucopolysaccharidosis

 

 

dystrophy, 191–2

Cryptococcus choroiditis,

keratopathy, 203

 

 

posterior amorphous

353

vortex keratopathy, 203

 

 

dystrophy, 190

Cryptophthalmos, 124

Wilson’s disease, 203

 

 

posterior polymorphous

Crystalens, 238

Deprivation amblyopia, 576

 

 

dystrophy, 192

Crystalline keratopathies,

Dermatochalasis, 122

 

 

stromal, 187–8, 189–90

203

Dermoids, 485

 

 

avellino dystrophy, 188

infectious, 203

cyst, 485

 

 

congenital hereditary

mucopolysaccharidosis,

Descemet’s membrane, 160

 

 

stromal dystrophy,

203

Descemet’s stripping

 

 

 

 

189

Cyclic esotropia, 585

endothelial keratoplasty

 

 

granular dystrophy,

Cyclodiode, 297

(DSEK), 206

 

 

187–8

Cyclopentolate, 178, 325

Developmental

 

 

lattice dystrophy types,

Cyclophosphamide, 335,

abnormalities, 635–7

 

 

187

709, 710

Devic’s disease, 523

 

 

macular dystrophy, 189

Cycloplegia, 100–1, 168,

Dexamethasone, 100–1,

 

 

Schnyder’s crystalline

174–5, 175–6, 176

147, 147, 198, 254, 285,

 

 

dystrophy, 189

Cyclosporine, 147, 335,

325, 429

 

 

Corneal ectasias, 193–4

338, 340, 342, 344,

Diabetes and cataract

 

 

keratoconus, 193–4

709, 710

surgery, 249

 

 

keratoglobus, 194

Cystic lesions

Diabetes Control and

 

 

pellucid marginal

cephalocele, 486

Complication Trial

 

 

degeneration, 194

dacryops, 485

(DCCT), 419

 

 

posterior keratoconus,

dermoid cyst, 485

Diabetic eye disease

 

 

194

mucocele, 485–6

assessment, 420, 421

 

 

Corneal foreign bodies and

Cystoid macular edema

definitions in, 422

 

 

abrasions, 99

(CME), 429, 430

general, 418–19

 

 

Corneal imaging techniques,

Cytomegalovirus (CMV),

laser procedures in, 466–7

 

 

68–70

346

management

 

 

anterior segment OCT, 69

retinitis, 352

recommendations

 

 

confocal scanning laser

D

for, 425

 

 

ophthalmoscopy, 70

management, 423–4

 

 

corneal topography, 68

screening, 425

 

 

corneal ultrasonic

Daclizumab, 370

Diagnosis, aids to

 

 

pachymetry, 69

Dacryoadenitis, 484

acute red eye, 648

 

 

scanning-slit

Dacryocystitis

anisocoria, 659–60

 

 

videokeratography, 68

acute, 134

diplopia, 657–8

 

 

Scheimpflug camera, 69

chronic, 134

flashes and floaters, 654

 

 

Corneal infiltrate culture, 167

Dacryocystography (DCG),

gradual loss of vision,

 

 

Corneal iron lines

75

651–2

 

 

ophthalmic signs, 666

Dacryocystorhinostomy

headache, 655–6

 

 

Corneal scrapes,

(DCR), 133

ophthalmic signs

 

 

microbiological

Dacryops, 485

anterior segment, 665–6

 

 

processing of, 167

Daily wear vs. extended

external, 663–4

 

 

Corneal signs, 162–3

wear lenses, 212

posterior segment,

 

 

endothelial signs, 163

Dark adaptometry, 74

671–2

 

 

epithelial signs, 162

Deep lamellar endothelial

visual fields, 675–6

 

 

iron lines, 162

keratoplasty (DLEK), 206

nystagmus, 661–2

 

 

stromal signs, 163

Deep lamellar keratoplasty

sudden or recent loss of

 

 

Corneal topography, 68

(DLK), 206

vision, 649–50

 

 

Corneal transparency,

superficial lamellar

watery eye, 653

 

 

160–1

keratoplasty, 206

Didanosine, 438

 

 

Corneal ultrasonic

Deferoxamine, 437–8

Diethylcarbamazine, 365

 

 

pachymetry, 69

Degenerative myopia, 431

Diffuse choroidal

 

 

Corrected pattern standard

Deletion syndromes, 638

hemangioma, 501

 

 

deviation (CPSD), 54

Dellen, 199

Diffuse non-necrotizing

 

 

Corticosteroids, 335, 342,

Demyelinating optic neuritis,

scleritis, 221

 

 

563, 700

522–3

Diffuse unilateral subacute

 

 

Cotrimoxazole, 362

Deposition keratopathies,

neuroretinitis (DUSN),

 

 

Cover–uncover test, 30

203

365

 

 

Cranial nerves III, IV, and

crystalline keratopathies,

Diplopia, 310, 578, 657–8,

 

 

VI, 517

203

682

 

 

728

INDEX

 

 

 

binocular, 657–8

pattern electroretinogram,

 

 

monocular, 657

73

 

 

Directly observed therapy

visual evoked potentials,

 

 

(DOT), 355

73–4

 

 

Direct ophthalmoscope, 24

Electro-oculography

 

 

Disciform keratitis, 176

(EOG), 73

 

 

Distance acuity, 5

Electroretinogram (ERG),

 

 

drugs and allergies, 4

71–2, 323

 

 

family history, 4

Embryology, of eye, 600–1

 

 

history of presenting

anterior segment, 600–1

 

 

 

 

illness, 2

germinal layers, 603

 

 

past medical history, 2

globe, 600

 

 

past ophthalmic history, 2

nasolacrimal drainage

 

 

presenting illness, 2

system, 603

 

 

social history, 4

posterior segment, 602–3

 

 

Distance esotropia, 585

Endophthalmitis, 305

 

 

Distichiasis, 108

prophylaxis and treatment

 

 

Doppler ultrasound, 59

of, 256

 

 

Dorzolamide/timolol, 294

Endothelium, 160

 

 

Down syndrome, 638

Enhanced corneal

 

 

clinical features, 638

compensator (ECC),

 

 

Doxycycline, 147, 180,

66–7

 

 

198, 360

Entropion, 119–20

 

 

Driving standards, 681–2

cicatricial, 119

 

 

blepharospasm, 682

congenital, 120

 

 

diplopia, 682

involutional, 119

 

 

monocularity, 682

surgical procedures, 120

 

 

visual acuity, 681

upper lid, 120

 

 

visual fields, 681

Epiblepharon, 124

 

 

Drug-induced cicatricial

Epibulbar choristoma

 

 

conjunctivitis (DICC),

dermoids, 156

 

 

149

lipodermoid, 156

 

 

Drugs and allergies, 4

Epicanthic folds, 124

 

 

Dry eyes, causes of, 151

Episclera

 

 

Duane syndrome, 590–1

anatomy, 218

 

 

classification of, 590

ophthalmic signs, 668

 

 

Dye disappearance test, 38

physiology, 218

 

 

Dysthyroid eye disease.

Episcleritis

 

 

See Thyroid eye disease

nodular, 220

 

 

(TED)

simple, 220

 

 

Dystonias, 568

Epithelial down-growth, 289

 

 

E

Epithelial keratitis, 174–5

 

 

Epithelium, 160

 

 

Epstein–Barr virus (EBV),

 

 

Ectopia lentis, 258–60

512

 

 

Ectropion, 117–18

Erythromycin, 147, 198, 360

 

 

cicatricial, 117

Esophoria, 582

 

 

congenital, 118

Esotropia, 582, 582, 584–5

 

 

involutional, 117

accommodative, 584

 

 

mechanical, 117

nonaccommodative, 585

 

 

paralytic, 118

pseudoesotropia, 585

 

 

surgical procedures, 118

secondary, 585

 

 

Edinger–Westphal nucleus,

Esterman grid, 56

 

 

518

Etanercept, 709, 710

 

 

Edwards syndrome, 638

ETDRS chart, 7

 

 

clinical features, 639

Ethambutol, 351, 355

 

 

Electrodiagnostic tests, 71–2

Exophoria, 583

 

 

dark adaptometry, 74

Exotropia, 583, 583, 586–7

 

 

electro-oculography, 73

consecutive, 587

 

 

electroretinography, 71–2

constant, 586

 

 

Goldmann–Weekers

intermittent, 586–7

 

 

adaptometry, 74

pseudoexotropia, 587

secondary, 587 Exposure keratopathy,

201–2

in TED, 476 Extracapsular cataract

extraction (ECCE), 246 Extraocular muscles

anatomy of, 572 congenital fibrosis of, 592 physiology of, 572

Exudative retinal detachment (ERD), 375

Eye alignments abnormal, 611, 612

Eyelash disorders, 108 lash infestations, 108 lash poliosis, 108 madarosis, 108 misdirected lashes, 108

Eyelashes and skin, 104 Eye movements

abnormal, 611, 612 anatomy of, 574 physiology of, 574

Eyepiece, 13

Eye size, abnormal, 616 Eyestrain, 656

F

Facial pain, 656 False negatives, 53 False positives, 53 Famciclovir, 177

Familial adenomatous polyposis (FAP), 510

Familial drusen, 460 Familial exudative

vitreoretinopathy (FEVR), 634

Family history (FH), 4 Farnsworth-D15 test, 11 Farnsworth–Munsell

100-Hue test, 12 Fat pads, 106

Ferrous foreign body, 96 Ferry’s line, 162

Fibrous histiocytoma, 491 Filtration surgery, for

glaucoma antimetabolites, 302 complications, 304–5 trabeculectomy, 299–301

Fixation losses, 53 Flashes, 654 Fleischer line, 162 Floaters, 654

Floppy eyelid syndrome, 124 Floxacillin, 472, 473 Flucinolone, 370

Fluid attenuated inversion recover (FLAIR), 77

 

 

INDEX

729

Fluorescein angiography

Glaucoma

Glycosaminoglycan

 

 

(FA), 323, 60–2

anatomy, 262–3

metabolism disorders,

 

 

contraindications, 60–2

assessment, 264

642

 

 

indications, 60–2

and cataract surgery, 249

Goldmann 3-mirror lens, 24

 

 

interpretation, 60–2

in children, 630–1

Goldmann perimetry, 50,

 

 

method, 60–2

causes, 630–1

51–2

 

 

reporting on, 62

clinical features, 631

calibrating, 51–2

 

 

side effects, 60–2

treatment, 631

interpretation, 51–2

 

 

Fluoromethalone, 146, 147

chronic glaucoma diseases,

method, 51–2

 

 

Fluoroquinolones, 168

276

results, 51–2

 

 

5-Fluorouracil (5-FU),

filtration surgery

Goldmann–Weekers

 

 

289, 302

antimetabolites, 302

adaptometry, 74

 

 

Flurbiprofen, 221

complications, 304–5

Gonioscopy, 24–5

 

 

Focimetry, 44–5

trabeculectomy, 299–301

Shaffer classification, 20

 

 

automated focimetry, 44

glaucoma drainage device

Spaeth classification, 20

 

 

manual focimetry, 44

surgery, 308–9

Gonococcal neonatal

 

 

Fomivirsen, 347

iatrogenic glaucoma,

conjunctivitis, 621

 

 

Foscarnet, 347

290–1

Granular dystrophy, 187–8

 

 

Fourth nerve, 516

inflammatory glaucoma,

Graves eye disease. See

 

 

disorders, 550, 551

281–2

Thyroid eye disease

 

 

Frequency doubling

intraocular pressure, 263

(TED)

 

 

perimetry (FDP), 56

lowering agents,

Graves’ disease, 475

 

 

Fuchs’ endothelial dystrophy

pharmacology of,

Gyrate atrophy, 462–3

 

 

(FED), 191–2

292–4

H

 

 

Fuchs’ heterochromic

laser procedures for,

 

 

iridocyclitis (FHI),

295–7

 

 

283, 327

lens-related glaucoma,

Haemophilus, 621–2

 

 

Functional visual loss,

284–5

Hamartomas, 637

 

 

569–70

neovascular glaucoma,

Hansen disease. See Leprosy

 

 

Fundus (chorioretinal)

279–80

Hard lenses, 211

 

 

ophthalmic signs, 671–2

normal-tension glaucoma,

Hardy–Rand–Rittler

 

 

Fundus albipunctatus, 458

271–2

plates, 11

 

 

Fungal keratitis, 172–3

ocular hypertension,

Hashimoto’s thyroiditis, 475

 

 

clinical features, 172

267–8

Headache, 655–6

 

 

investigation, 172–3

physiology, 262–3

Heerfordt’s syndrome, 339

 

 

risk factors, 172

phacolytic, 231

Heidelberg retinal

 

 

treatment, 173

phacomorphic, 230

tomography (HRT), 66

 

 

Fungal uveitis

pigment dispersion

contraindications, 66

 

 

aspergillosis, 366

syndrome, 277

indications, 66

 

 

candidiasis, 366

primary angle-closure

interpretation, 66

 

 

histoplasmosis and POHS,

glaucoma, 273–4

method, 66

 

 

367

primary open-angle

results, 66

 

 

G

glaucoma, 269–70

Hematological disease

 

 

pseudoexfoliation

anemia, 451

 

 

syndrome, 275

hemoglobinopathies,

 

 

Gadolinium-enhanced

secondary closed-angle

450–1

 

 

scans, 77

glaucomas, 288–9

hyperviscosity, 451

 

 

Ganciclovir, 174–5, 347

secondary open-angle

leukemia, 451

 

 

Gatifloxacin, 254, 308–9

glaucomas, 286–7

Hemispheric BVO, 442

 

 

Gaze-evoked nystagmus

surgery, 298

Hemoglobinopathies, 450–1

 

 

(GEN), 558

triad, 265

Herpes simplex, 143

 

 

Genetic disorders of eye,

Glaucoma drainage device

Herpes simplex keratitis,

 

 

604

(GDD) surgery, 308–9

174–6

 

 

chromosomal locations of

Glaucoma secondary to lens

blepharoconjunctivitis,

 

 

gene, 605

subluxation/dislocation,

174

 

 

inheritance patterns, 604

285

disciform keratitis, 176

 

 

Gentamicin, 168

Glipizide, 424

epithelial keratitis, 174–5

 

 

Ghost cell glaucoma, 286

Glitazone, 424

stromal keratitis, 175–6

 

 

Giant cell arteritis (GCA),

Globe of eye, 600

Herpes simplex virus (HSV),

 

 

524, 525

ophthalmic signs, 663

345

 

 

Giant papillary conjunctivitis,

Glyburide, 424

neonatal conjunctivitis,

 

 

215

Glycerol, 705

622

 

 

730

INDEX

 

 

 

 

Herpes viral group (HSV,

interpretation, 53

Fuchs’ heterochromic

 

 

VZV, CMV) anterior

Hyaloid remnants, 635

iridocyclitis, 283

 

 

uveitis, 326

Hydrodissection, 243

open-angle type, 281

 

 

keratouveitis, 349

Hydrogel (soft) lenses, 211

Posner–Schlossman

 

 

Herpes zoster ophthalmicus

Hydroxyamphetamine, 554

syndrome, 283

 

 

(HZO), 177–8

Hydroxychloroquine, 435

Infliximab, 335, 340, 709,

 

 

keratitis, 177–8

Hyperfluorescence, 61, 64

710

 

 

systemic and cutaneous

Hypertensive retinopathy,

Insulin, 424

 

 

disease, 177

448–9

Interferon-α, 709, 710

 

 

 

 

Herpetic Eye Disease Study

chronic hypertension, 448

Intermediate uveitis, 333

 

 

 

 

(HEDS), 174–5

malignant hypertension,

associations of, 334

 

 

Hirschberg test, 30

448–9

clinical features, 333

 

 

Histoplasma capsulatum, 367

Hyperviscosity, 451

treatment, 333

 

 

Histoplasmosis and POHS,

Hyphema, 100–1

Intermittent exotropia,

 

 

367

high-risk features in, 101

586–7

 

 

History of presenting illness

Hypofluorescence, 61, 64

Internuclear

 

 

(HPI), 2, 66

Hypoxia, 610

ophthalmoplegia (INO),

 

 

HIV-associated disease,

I

544, 559

 

 

349–51

Intracapsular cataract

 

 

anterior uveitis, 351

extraction (ICCE), 246

 

 

CD4 level and typical

Iatrogenic glaucoma, 290–1

Intracranial bleeding, 610

 

 

diseases, 350

Idiopathic intracranial

Intraocular-foreign body

 

 

CMV retinitis, 352

hypertension, 533, 534

(IOFB), 95–6, 97–8

 

 

conjunctival

Idiopathic juxtafoveal retinal

removal, 98

 

 

microvasculopathy, 349

telangiectasia, 453

Intraocular lens (IOL), 239,

 

 

cryptococcus choroiditis,

Idiopathic orbital

240, 245, 247–8

 

 

353

inflammatory disease,

anterior chamber

 

 

HIV microvasculopathy,

483

intraocular lens

 

 

353

Idiopathic polypoidal

(ACIOL), 248

 

 

immune recovery uveitis,

choroidal vasculopathy

choice of lens, 247

 

 

353

(IPCV), 453–4

posterior chamber

 

 

keratouveitis, 349

IgA nephropathy, 328

intraocular lens

 

 

mycobacterium

Illumination filters, 13–14

(PCIOL), 247–8

 

 

tuberculosis, 351

Image blurring, from

Intraocular pressure (IOP),

 

 

ophthalmic complications,

refractive error, 576

262–3, 648

 

 

350

Immune recovery uveitis,

-lowering agents,

 

 

Pneumocystis carinii

353

pharmacology of,

 

 

choroiditis, 352–3

Immunoglobulin, 563

292–4

 

 

syphilis choroiditis/

Incominant strabismus,

Intraocular tumors

 

 

chorioretinitis, 353

588–9

astrocytoma, 509

 

 

toxoplasma

mechanical, 588, 589

choroidal hemangiomas,

 

 

retinochoroiditis, 352

myasthenic, 588

501

 

 

HLA-B27

myopathic, 589

circumscribed choroidal

 

 

-associated AAU, 325

neurogenic, 588

hemangioma, 501

 

 

-related arthropathies,

Incontinentia pigmenti, 634

diffuse choroidal

 

 

329–30

Indirect ophthalmoscope

hemangioma, 501

 

 

Homonymous

and scleral indentor, 23

Sturge–Weber

 

 

definition of, 48

method, 23

syndrome, 502

 

 

hemianopia, 49

optical features, 23

choroidal melanoma,

 

 

Horizontal gaze palsy, 544

scleral indentation, 23

497–9

 

 

Horner’s syndrome, 554

Indocyanine green

clinical features, 497

 

 

causes of, 555

angiography (ICG), 63

differential diagnosis, 498

 

 

investigations of, 555

contraindications, 63

investigations, 498

 

 

Hudson–Stahli line, 162

indications, 63

prognosis, 499

 

 

Human immunodeficiency

interpretation, 63

treatment, 498

 

 

virus (HIV-1 and 2),

method, 63

choroidal metastasis,

 

 

349–51

side effects, 63

503–4

 

 

Human T-lymphotropic

Infantile esotropia, 585

choroidal nevus, 500

 

 

virus type-1 (HTLV-1),

Infantile exotropia, 586

choroidal osteoma, 503

 

 

346

Inflammatory glaucoma,

ciliary body tumors

 

 

Humphrey perimetry, 53

281–2

ciliary body melanoma,

 

 

Humphrey visual field, 53

angle closure type, 282

496

medulloepithelioma, 496 differential diagnosis, 496

iris tumors

iris nevus, 495 melanoma, 494, 495 metastasis, 495 uveal melanoma, 494

lymphoma, 512 retinal hemangiomas

capillary hemangioma, 507

cavernous hemangioma, 508

racemose hemangioma, 508

retinoblastoma (Rb), 505–6

RPE tumors

congenital hypertrophy of the retinal pigment epithelium (CHRPE), 510

combined hamartoma of the RPE and retina, 510–11

Intraoperative floppy iris syndrome (IFIS), 249

Intrauterine infections, 619 Intravitreal injection in

retinal diseases, 468 Investigations, and

interpretation automated perimetry

performance and interpretation, 53

protocols, 56 corneal imaging

techniques, 68–70 electrodiagnostic tests,

71–2

fluorescein angiography (FA), 60–2

Goldmann perimetry, 50 Heidelberg retinal

tomography (HRT), 66 indocyanine green

angiography (ICG), 63 ophthalmic

ultrasonography, 57 optical coherence

tomography (OCT), 65–6

scanning laser polarimetry (SLP), 66–7

visual field testing, 48–50 ophthalmic radiology

MRI and MRA, 77–8

X-ray, DCG, and CT, 75–6

Involuntary facial movement disorders, 568

Involutional ectropion, 117

Involutional entropion, 119 Involutional ptosis, 121 Iridocorneal endothelial

syndrome (ICE), 288 Iridoschisis, 288

Iris, 314, 315, 601 ophthalmic signs, 669 tumors

iris nevus, 495 melanoma, 494, 495 metastasis, 495 uveal melanoma, 494

Iron lines, 162 Irrigation, 39

Irrigation and aspiration (IA), 245

Irvine–Gass syndrome, 257 Ishihara

pseudo-isochromatic plates, 11

Isolated congenital ptosis, 123

Isoniazid, 351, 355 Isopter, 48, 50 Ivermectin, 365

Ixodes dammini, 359–60 Ixodes pacificus, 359–60

J

Jones testing, 39

Juvenile idiopathic arthritis (JIA), 331–2, 628

K

Kaposi’s sarcoma, 116 Kawasaki disease, 328 Keeler acuity cards, 9

schematic example of, 10 Keratitis, common bacterial

causes of, 167 Keratoacanthoma, 114 Keratoconjunctivitis sicca,

150–1 Keratoconus, 193–4 Keratoglobus, 194 Keratoplasty

complications, 207–8 early postoperative, 207

graft rejection, 208 late postoperative, 207

principles, 205–6 deep lamellar

keratoplasty, 206 DSEK and DLEK, 206 penetrating keratoplasty,

205–6 superficial lamellar

keratoplasty, 206 triple procedure, 206

Keratouveitis, 349

INDEX 731

Ketoro-lac, 429

Kjer syndrome, 528

Krimsky test, 30

L

Lacrimal anatomy, 128–9 infections, 134

acute dacryocystitis, 134 canaliculitis, 134 chronic dacryocystitis,

134 physiology, 128–9 watery eye

assessment, 130 causes, 131

systemic approach to assess, 130

treatment, 132–3 Lacrimal carcinomas, 487 Lacrimal ductal cyst, 485 Lacrimal gland, 128, 487 λ–pattern, 594 Lambert–Eaton myasthenic

syndrome (LEMS), 564 Lamella

anterior, 112, 114 posterior, 112–13

Langerhans cell histiocytosis (LCH), 490

Laser iridoplasty, 296–7 Laser procedures, in

diabetic eye disease, 466–7

Laser stromal in situ keratomilieusis (LASIK), 209

Laser subepithelial keratomilieusis (LASEK), 209–10

Laser trabeculoplasty, 295–6 Lash infestations, 108

Lash poliosis, 108 causes, 109

Lateral geniculate nucleus (LGN), 515

Lateral wall, 88

Lattice dystrophy types, 187 Leber’s hereditary optic

neuropathy (LHON), 528 Leber’s miliary aneurysms,

453 Lens, 600

abnormalities, 259 ectopia lentis, 258–60

anatomy capsule, 228 epithelium, 228 fibers, 228 zonules, 228

cataract

732

INDEX

 

 

 

 

age of onset, 232

Leptospira interrogans, 359

cicatricial, 119

 

 

clinical presentations,

Leukemia, 451

congenital, 120

 

 

230–1

Leukocoria, 617

involutional, 119

 

 

grade, 232

Levator palpebrae superioris

upper lid, 120

 

 

maturity of cataract, 232

(LPS), 106, 516

examination, 34–5

 

 

morphology, 232

Levocabastine, 146

Cogan’s twitch, 34

 

 

pathogenesis, 230

Levothyroxine, 482

fatiguability, 34

 

 

risk factors, 230

Lid apraxia, 568

jaw-winking, 35

 

 

types, 233

Lid lacerations, 90

normal lid

 

 

cataract surgery

assessment, 90

measurements, 35

 

 

assessment for, 234–5

repair for, 91

eyelash disorders, 108

 

 

complications, 251–3

specific features in

lash infestations, 108

 

 

and concurrent eye

assessment of, 90

lash poliosis, 108

 

 

disease, 249–50

treatment, 90

madarosis, 108

 

 

consent and planning,

Lid lumps

misdirected lashes, 108

 

 

236–7

anterior lamella, 112

lid lumps

 

 

perioperative, 239–40

basal cell carcinoma, 115

anterior lamella, 112

 

 

postoperative, 241

benign tumors, 114

basal cell carcinoma, 115

 

 

extracapsular cataract

Kaposi’s sarcoma, 116

benign tumors, 114

 

 

extraction, 246

malignant melanoma, 116

Kaposi’s sarcoma, 116

 

 

intracapsular cataract

Merkel cell carcinoma, 116

malignant melanoma,

 

 

extraction, 246

posterior lamella, 112–13

116

 

 

intraocular lenses, 247–8

premalignant tumors, 114

Merkel cell carcinoma,

 

 

choice of, 247

sebaceous gland

116

 

 

posterior chamber

carcinoma, 115–16

posterior lamella,

 

 

intraocular lens,

squamous cell carcinoma

112–13

 

 

247–8

(SCC), 115

premalignant tumors,

 

 

anterior chamber

Lidocaine, 690

114

 

 

intraocular lens, 248

Lidocaine/phe-nylephrine,

sebaceous gland

 

 

ophthalmic signs, 670

325

carcinoma, 115–16

 

 

optical properties of, 26

Lid retraction, 125

squamous cell

 

 

physiology, 228–9

causes, 125

carcinoma, 115

 

 

phacoemulsification,

Lid retractors, 106

ophthalmic signs, 664

 

 

242–3, 244–5

Lids

ptosis

 

 

continuous curvilinear

acquired lid disorders, 124

acquired, 121–2

 

 

capsulorhexis, 242–3

anatomy and physiology,

congenital, 123

 

 

hydrodissection, 243

104, 105

Ligneous conjunctivitis, 152

 

 

incision, 242

arterial supply, 107

Lipid keratopathy

 

 

intraocular lens, 245

canthal tendons, 106

primary, 181

 

 

irrigation and aspiration,

conjunctiva, 106

secondary, 181–2

 

 

245

fat pads, 106

Lipid metabolism disorders,

 

 

ophthalmic viscosurgical

lid retractors, 106

641

 

 

devices, 242

lymphatic drainage, 107

Locked-in syndrome, 545

 

 

preparation, 242

nerves, 107

Lodoxamide, 146

 

 

wound closure, 245

orbicularis oculi, 104

Lofgren’s syndrome, 339

 

 

postoperative cystoid

orbital septum and tarsal

LogMAR charts, 7

 

 

macular edema

plates, 106

schematic example of, 8

 

 

Irvine–Gass syndrome,

skin and eyelashes, 104

Low vision, 678–9

 

 

257

venous drainage, 107

assessment, 678

 

 

postoperative

blepharitis, 110–1

management, 679

 

 

endophthalmitis

bacterial blepharitis, 110

Lyme disease, 359–60

 

 

acute postoperative

meibomianitis, 110

Lymphangioma, 489

 

 

endophthalmitis,

seborrheic blepharitis,

Lymphatic drainage, 107

 

 

254–5

111

Lymph nodes, ophthalmic

 

 

chronic postoperative

congenital lid disorders, 124

signs, 663

 

 

endophthalmitis, 255

ectropion, 117–18

Lymphoproliferative tumors

 

 

presbyopia correcting

cicatricial, 117

benign reactive lymphoid

 

 

strategies, 238

congenital, 118

hyperplasia, 490

 

 

accomodative lens, 238

involutional, 117

langerhans cell

 

 

multifocal lenses, 238

mechanical, 117

histiocytosis, 490

 

 

-related glaucoma, 284–5

paralytic, 118

malignant orbital

 

 

Leprosy, 355–6

entropion, 119–20

lymphoma, 490

M

Macroaneurysm, 453, 454 Macula, ophthalmic signs,

673

Macular dystrophies, 189, 459–60

adult vitelliform degeneration, 460

Best’s disease, 459, 460 central areolar choroidal

dystrophy, 461

cone degenerations, 461 dominant CME, 461 familial drusen, 460 North Carolina macular

dystrophy, 461 pattern dystrophy, 460 progressive bifocal

chorioretinal atrophy, 461

Sorsby’s macular dystrophy, 461

Stargardt’s disease and fundus flavimaculatus, 459

Macular laser, 466–7 Madarosis, 108

causes, 109 Maddox rod, 31 Maddox wing, 31 Magnetic resonance

angiography (MRA), 78 Magnetic resonance imaging

(MRI), 77 Magnetic resonance

venography (MRV), 78 Malignant melanoma, 116 Malignant orbital lymphoma,

490 Mannitol, 705

Mannitol/glycerol, 290 Mantoux testing, 355 Marcus Gunn jaw winking

syndrome, 123 Marginal keratitis, 198 Maxillary bone, 87 Mechanical ectropion, 117 Mechanical ptosis, 122 Mechanical strabismus, 588 Medial wall fractures, 87 Medical retina

age-related macular degeneration, 408

neovascular, 410–3 non-neovascular, 408

albinism, 464 ocular, 464

oculocutaneous, 464, 465 laser procedures, in

diabetic eye disease, 466–7

 

INDEX

733

panretinal

Stargardt’s disease and

 

 

photocoagulation,

fundus flavimaculatus,

 

 

466

459

 

 

macular laser, 466–7

photodynamic therapy,

 

 

anatomy, 406–7

416–17

 

 

angioid streaks, 433

physiology, 407

 

 

anti-VEGF therapy, 415

radiation retinopathy, 455

 

 

central serous

clinical features, 455

 

 

chorioretinopathy,

treatment, 455

 

 

 

 

426–7

retinal artery occlusion,

 

 

choroidal dystrophies,

443–5

 

 

462–3

branch retinal arteriolar

 

 

choroidal atrophies, 463

occlusion, 446

 

 

choroideremia, 462

central retinal artery

 

 

gyrate atrophy, 462–3

occlusion, 443–5

 

 

choroidal folds, 434

cilioretinal artery

 

 

choroidal neovascular

occlusion, 446

 

 

membrane, causes

hollenhorst plaque, 447

 

 

of, 414

retinal vein occlusion,

 

 

congenital stationary night

439–40

 

 

blindness, 458

branch retinal vein

 

 

cystoid macular edema,

occlusion, 442

 

 

429, 430

central retinal vein

 

 

degenerative myopia, 431

occlusion, 439–40,

 

 

diabetic eye disease

441, 441

 

 

assessment, 420

hemispheric BVO, 442

 

 

definitions in, 422

retinitis pigmentosa,

 

 

general, 418–19

456, 457

 

 

management, 423–4

toxic retinopathies, 435–6

 

 

screening, 425

chloroquine, 435

 

 

hematological disease

chlorpromazine, 437

 

 

anemia, 451

clofazimine, 438

 

 

hemoglobinopathies,

deferoxamine, 437–8

 

 

450–1

didanosine, 438

 

 

hyperviscosity, 451

hydroxychloroquine, 435

 

 

leukemia, 451

tamoxifen, 437

 

 

hypertensive retinopathy,

thioridazine, 437

 

 

448–9

vigabatrin, 436

 

 

chronic hypertension,

vascular anomalies

 

 

448

Coats’ disease, 452

 

 

malignant hypertension,

idiopathic juxtafoveal

 

 

448–9

retinal telangiectasia,

 

 

intravitreal injection in

453

 

 

retinal diseases, 468

idiopathic polypoidal

 

 

macular dystrophies,

choroidal

 

 

459–60

vasculopathy, 453–4

 

 

adult vitelliform

Leber’s miliary

 

 

degeneration, 460

aneurysms, 453

 

 

Best’s disease, 459, 460

macroaneurysm, 453

 

 

central areolar choroidal

retinal telangiectasias,

 

 

dystrophy, 461

452

 

 

cone degenerations, 461

Medulloepithelioma, 496

 

 

dominant CME, 461

Meesman’s dystrophy,

 

 

familial drusen, 460

185–6

 

 

North Carolina macular

Megalopapilla, 536

 

 

dystrophy, 461

Meibomianitis, 110

 

 

pattern dystrophy, 460

Merkel cell carcinoma, 116

 

 

progressive bifocal

Metabolic and storage

 

 

chorioretinal atrophy,

diseases, 640

 

 

461

Metaplastic lashes, 108

 

 

Sorsby’s macular

Metformin, 424

 

 

dystrophy, 461

Methazolamide, 705

 

 

734 INDEX

Methotrexate, 335, 338, 342, 709, 710

Methylprednisolone, 335, 342, 344, 429, 522–3, 524

and triamcinolone, 429 Methylprednisone, 476 Metronidazole, 472, 473 Mickulicz’s syndrome, 339 Microbial keratitis, 215

acanthamoeba, 170–2 clinical features, 170 initial treatment, 170–1 investigation, 170 ongoing treatment, 171 prevention, 171–2

risk factors, 170 treatment of

complications, 171 assessment, 166 bacterial causes of, 167 corneal scrapes,

microbiological processing of, 167

risk factors, 166 treatment, 168–9

initial, 168 ongoing, 168–9

of complications, 169 Micropulse laser

trabeculoplasty (MLT), 295–6

Microsporidial keratouveitis, 349

Microsporidiosis, 363 Microtropia, 579 Migraine, 541–2, 655

classification, 542 ophthalmic complications

of, 542 Mineral metabolism

disorders, 642 Miotics, 293, 294 Misdirected lashes, 108 Mitomycin-C (MMC), 302 Möbius syndrome, 591 Molluscum contagiosum,

142–3 Monocularity, 682 Mooren’s ulcer, 196–7 Morning glory anomaly,

536 Moxifloxacin, 254 Mucocele, 485–6

Mucoepidermoid carcinoma, 157

Mucopolysaccharidosis, 642 keratopathy, 203

Mucormycosis, 474 Muller’s muscle, 106 Multifocal choroiditis with

panuveitis (MCP), 371 Multifocal lenses, 238

Multiple evanescent

onchocerciasis, 365

white-dot syndrome

toxocariasis, 364

(MEWDS), 371

Neovascular glaucoma

Myasthenia gravis (MG),

(NVG), 279–80

562–3

Neovascularization, 216

Myasthenic ptosis, 122

Nephrogenic systemic

Myasthenic strabismus,

fibrosis (NSF), 77

588–9

Nerve fiber analyzer (GDx),

Mycobacterial disease, 354–6

66–7

leprosy, 355–6

Nerves, 107

tuberculosis, 354–5

Neural retina, 406, 407

Mycobacterium tuberculosis,

Neurofibroma, 488

351, 354–5

Neurofibromatosis, 644

Mycophenolate, 335, 709,

clinical features of, 644

710

Neurofibromatosis-1

Mydriatics and cycloplegics,

(NF-1), 5

704

Neurogenic ptosis, 121

contraindications, 706

Neurogenic strabismus,

efficacy, 706

588, 589

indications and

Neuromuscular junction

mechanism, 706

disorders, 562–4

monitoring, 706–7

Lambert–Eaton myasthenic

routes of administration,

syndrome, 564

706

myasthenia gravis (MG),

side effects, 707

562–3

avoiding, 708

Neuro-ophthalmology

systemic corticosteroids

Adie’s tonic pupil, 556

systemic medication, 705

anatomy and physiology

Myopathic ptosis, 122

autonomic supply, 518

Myopathic strabismus, 589

cerebrospinal fluid, 518

Myopathies, 565–6

cranial nerves III, IV, and

chronic progressive

VI, 517

external

ocular motor nerves, 516

ophthalmoplegia

optic chiasm, 514

(CPEO), 565

optic nerve, 514

myotonic dystrophy, 566

optic radiation, 515

oculopharyngeal

optic tract and lateral

dystrophy, 565

geniculate nucleus,

Myopia, 431, 432

515

Myositis, 484

visual cortex, 515

Myotonic dystrophy, 566

anterior ischemic optic

N

neuropathy (AION),

524

arteritic, 524

Nasolacrimal drainage

nonarteritic, 526, 527

system, 603

posterior ischemic optic

Nasolacrimal duct

neuropathy, 526

abnormalities in, 636

blepharospasm, 567–8

Nasolacrimal system, 128

chiasmal disorders, 537,

examination, 38–9

538

dye disappearance

coma-associated eye

test, 38

movements, 561

irrigation, 39

congenital optic disc

Jones testing, 39

anomalies, 535–6

probing, 38

megalopapilla, 536

Nd-YAG peripheral

morning glory anomaly,

iridotomy (PI), 295

536

Near esotropia, 585

optic disc coloboma, 536

Nematodal uveitis

optic disc pit, 535

diffuse unilateral subacute

optic nerve hypoplasia,

neuroretinitis (DUSN),

535

365

tilted disc, 535

 

 

INDEX

735

dystonias, 568

Neurotrophic keratopathy,

Ocular pain, 656

 

 

fourth nerve disorders,

200

Ocular trauma, 80–1

 

 

550, 551

Nevi, 114

Oculopharyngeal dystrophy,

 

 

functional visual loss,

Nodular non-necrotizing

565

 

 

569–70

scleritis, 222

Ofloxacin, 141, 168

 

 

Horner’s syndrome, 554

Nonproliferative diabetic

Oguchi’s disease, 458

 

 

causes of, 555

retinopathy (NPDR), 421

Older child

 

 

investigations of, 555

Nonrefractive contact

conjunctivitis in, 622

 

 

idiopathic intracranial

lenses, 214

recognition tests for, 9

 

 

hypertension, 533, 534

Nonrefractive esotropia,

Onchocerca volvulus, 365

 

 

 

 

involuntary facial movement

584

Onchocerciasis, 365

 

 

disorders, 568

Normal/near normal vision,

One-and-a-half syndrome,

 

 

Leber’s hereditary optic

648

544

 

 

neuropathy (LHON),

Normal-tension glaucoma

Ophthalmia neonatorum,

 

 

528

(NTG), 271–2

621–2

 

 

lid apraxia, 568

North Carolina macular

Ophthalmic history,

 

 

neuromuscular junction

dystrophy, 461

obtaining, 2–4

 

 

disorders, 562–4

Nutritional and toxic optic

Ophthalmic radiology

 

 

myasthenia gravis (MG),

neuropathies, 528

computerized

 

 

562–3

Nutrition and nerve supply,

tomography, 75–6

 

 

Lambert–Eaton

161

dacryocystography, 75

 

 

myasthenic

Nystagmus, 557, 661–2

magnetic resonance

 

 

syndrome, 564

classification, 557

angiography, 78

 

 

optic atrophy, 529

early onset, 661

magnetic resonance

 

 

inherited, 528–9

early-onset/congenital

imaging, 77

 

 

optic neuropathy,

nystagmus, 557

magnetic resonance

 

 

assessment of, 519–20

late onset, 661–2

venography, 78

 

 

optic neuritis, assessment

late-onset or acquired

X-ray orbits, 75–6

 

 

of, 522–3

nystagmus, 558

Ophthalmic signs

 

 

migraine, 541–2

treatment, 560

anterior segment, 665–6

 

 

myopathies, 565–6

O

external, 663–4

 

 

chronic progressive

posterior segment, 671–2

 

 

external

visual fields, 675–6

 

 

ophthalmoplegia, 565 Ocular anesthesia, 690–1,

Ophthalmic

 

 

myotonic dystrophy, 566

692

ultrasonography, 57,

 

 

oculopharyngeal

peribulbar block, 690–1

58–9

 

 

dystrophy, 565

Subtenon’s block, 690

A-scans, 57

 

 

nutritional and toxic optic

topical anesthesia, 690

B-scans, 58

 

 

neuropathies, 528

Ocular cicatricial

Doppler ultrasound, 59

 

 

nystagmus, 557

pemphigoid (OCP), 148

Ophthalmic viscosurgical

 

 

classification, 557

Ocular hypertension

devices (OVDs), 242,

 

 

early-onset/congenital

(OHT), 267–8

243

 

 

nystagmus, 557

Ocular medication, 696–7

Optical coherence

 

 

late-onset or acquired

intravitreal injection, 697

tomography (OCT),

 

 

nystagmus, 558

subconjunctival injection,

65–6, 323

 

 

treatment, 560

696

indications, 65

 

 

papilledema, 530–2

subtenon and peribulbar

interpretation, 66

 

 

pseudopapilledema, 532

injections, 697

method, 65

 

 

retrochiasmal disorders,

topical, 696

results, 65

 

 

539–40

Ocular motility examination,

Optic atrophy, 529

 

 

saccadic oscillations, 561

29–30

inherited, 528–9

 

 

saccadic intrusions, 561

caloric tests, 32

Optic chiasm of, 514

 

 

sixth nerve disorders,

corneal reflection tests, 30

Optic disc, ophthalmic

 

 

552, 553

cover tests, 30

signs, 674

 

 

supranuclear eye

general approach, 29

Optic disc coloboma, 536

 

 

movement disorders,

Maddox tests, 31

Optic disc pit, 535

 

 

543–5

Parks–Bielschewsky 3-step

Optic fissure, abnormalities

 

 

horizontal gaze,

test, 32

in, 635

 

 

disorders of, 544–5

Ocular motor nerves, 517

Optic nerve, 514, 602

 

 

vertical gaze palsies, 546

Ocular mucous membrane

Optic nerve anomalies, 636

 

 

third nerve disorders,

pemphigoid (OMMP),

Optic nerve avulsion, 93

 

 

547–9

148

Optic nerve glioma, 487–8